ZOZO Q1: 5% GMV Growth Passes the Smell Test-But 20x Earnings Leave Little Room for Mistakes

ZOZO Q1 was solid, but not strong enough to silence valuation concerns

ZOZO's Q1 held up, but only just. Bulls can point to 5.1% GMV growth, net sales of 56,132 million yen (+3.9%), operating profit up 5.7%, and adjusted EBITA up 3.6% to a 12.0% margin. That suggests the core business is still growing and management is still running it efficiently. Bears will counter that this is exactly what a "show me" stock looks like when it carries an expensive multiple: steady enough to keep the story alive, but not strong enough to excuse a rich price.

The quarter mostly confirmed expectations

Management said Q1 GMV was on track with internal plans, with a weak June offset by stronger April and May performance. Full-year FY2027 guidance was also maintained. In other words, ZOZO validated the existing story rather than changing it.

The stock reaction reflected that mixed read. Shares rose 4.16% over five days, but remain down 16.11% year to date. At 19.7x forward earnings and a 3.57% yield, the market is already paying for compounding, not just steady operations. The buyback plan and expected ROE above 50% help the case, but they do not remove the need for real growth.

The other reminder is that total GMV still fell 1.6%. If growth stays this modest, a near-20x earnings multiple leaves limited room for disappointment.

Core GMV and LYST suggest the operating story is real, even if headline growth is muted

Core GMV is the cleaner read

The most important number is core GMV, which grew 5.1% to 156,694 million yen. That is a better read of the company's main platform than total GMV, which declined 1.6% after the discontinuation of certain contracts. Put simply, the pullback in total GMV appears to reflect scope changes more than a collapse in the core business.

LYST is still the clearest sign of consumer demand

LYST posted 30% top-line growth in Q1, while management said organic GMV growth outpaced currency effects. That is a stronger signal than the parent company's headline pace and suggests at least one major business unit is still gaining traction with users.

Margins held up, but the quarter still depended on operating discipline

Gross profit rose 3.4%, while gross profit margin fell to 33.5%, down 0.5 percentage points. SG&A increased 2.2%, and management said improved logistics and shipping costs helped offset higher depreciation and goodwill amortization. That supports the view that ZOZO is improving execution, but it also means margins remain sensitive to demand volatility because fixed costs are still working their way through the base.

What investors should watch next

Management also said banner and search ads remain flat, so this was not a quarter saved by a new monetization lever. The growth came from merchandise flow. Going forward, investors should watch whether LYST's stronger performance broadens across the business or fades, and whether June was an isolated soft patch rather than the start of a weaker trend.

Valuation already prices in steady compounding, so buybacks alone may not be enough

At EV/sales 3.96x for 2027 and 3.69x for 2028, ZOZO is already being valued like a steady compounding story rather than a deep-value opportunity. That setup works if the business keeps running cleanly, maintains earnings power, and shrinks the share count over time. But if that is all investors get, upside may be more modest than the current narrative implies.

The buyback is the most tangible support. Management has put in place repurchase and cancellation initiatives that it says should push ROE above 50%. If earnings hold up, that should help per-share growth even if operating progress remains only moderate. Combined with a 3.57% yield, it gives patient holders a reason to stay engaged.

Still, the distinction matters: capital return can support returns, but it does not replace the need for sustained business momentum.